Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine pretreatment to prevent MDMA-induced memory impairment
NL-OMON29601Not yet recruiting
- Sponsor
- Maastricht University
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Double-blind trial of memantine and midomafetamine (4 arms), sponsored by Maastricht University. Primary endpoint: Memory performance. Planned start Apr 2011; status: not yet recruiting.
02
Drugs
memantinemidomafetamine
Beyond the preview
Go deeper on NL-OMON29601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29601.